$86.50
0.61% yesterday
NYSE, Feb 04, 10:10 pm CET
ISIN
US1941621039
Symbol
CL

Colgate-Palmolive Stock price

$86.50
-1.04 1.19% 1M
-14.47 14.33% 6M
-4.41 4.85% YTD
+2.41 2.87% 1Y
+5.38 6.63% 3Y
+11.10 14.72% 5Y
+17.30 25.00% 10Y
NYSE, Closing price Tue, Feb 04 2025
-0.53 0.61%
ISIN
US1941621039
Symbol
CL

Key metrics

Market capitalization $70.67b
Enterprise Value $77.86b
P/E (TTM) P/E ratio 24.64
EV/FCF (TTM) EV/FCF 21.96
EV/Sales (TTM) EV/Sales 3.87
P/S ratio (TTM) P/S ratio 3.52
P/B ratio (TTM) P/B ratio 162.46
Dividend yield 2.29%
Last dividend (FY24) $1.98
Revenue growth (TTM) Revenue growth 3.30%
Revenue (TTM) Revenue $20.10b
EBIT (operating result TTM) EBIT $4.51b
Free Cash Flow (TTM) Free Cash Flow $3.55b
Cash position $1.10b
EPS (TTM) EPS $3.51
P/E forward 23.36
P/S forward 3.52
EV/Sales forward 3.88
Short interest 1.23%
Show more

Is Colgate-Palmolive a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Colgate-Palmolive Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Colgate-Palmolive forecast:

13x Buy
50%
9x Hold
35%
4x Sell
15%

Analyst Opinions

26 Analysts have issued a Colgate-Palmolive forecast:

Buy
50%
Hold
35%
Sell
15%

Financial data from Colgate-Palmolive

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
20,100 20,100
3% 3%
100%
- Direct Costs 7,939 7,939
2% 2%
39%
12,618 12,618
11% 11%
63%
- Selling and Administrative Expenses 7,650 7,650
17% 17%
38%
- Research and Development Expense - -
-
-
5,116 5,116
7% 7%
25%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 4,511 4,511
7% 7%
22%
Net Profit 2,890 2,890
26% 26%
14%

In millions USD.

Don't miss a Thing! We will send you all news about Colgate-Palmolive directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Colgate-Palmolive Stock News

Neutral
Forbes
one day ago
Colgate-Palmolive stock (NYSE: CL) recently reported its Q4 results, with revenues missing and earnings slightly ahead of the street estimates. The company reported revenue of $4.94 billion and adjusted earnings of $0.91 per share, compared to the consensus estimates of $4.99 billion and $0.89, respectively.
Negative
The Motley Fool
4 days ago
Shares of Colgate-Palmolive (CL -4.61%) pulled back today after the household products giant missed the mark on the top line in its fourth-quarter earnings report and gave a weak outlook.
Negative
Investopedia
5 days ago
Colgate-Palmolive (CL) shares fell 5% Friday after the household products company missed revenue forecasts and gave weak guidance as it was hurt by foreign exchange rates.
More Colgate-Palmolive News

Company Profile

Colgate-Palmolive Co. is engaged in the manufacturing and distribution of consumer products. It operates through Oral, Personal and Home Care and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors. The Pet Nutrition segment offers pet nutrition products for dogs and cats. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.

Head office United States
CEO Noel Wallace
Founded 1806
Website www.colgatepalmolive.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today